Re: erbB-2, p53, and efficacy of adjuvant therapy in lymph node- positive breast cancer [6] (multiple letters)

Journal of the National Cancer Institute

Volumn 91, Issue 8, 1999, Pages 728-729

  Cameron, D A ^a   Leonard, R C F ^a   Berry, D A ^a   Thor, A D ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; PROTEIN P53;

BREAST CANCER; CANCER ADJUVANT THERAPY; DOSE CALCULATION; DRUG EFFICACY; GENE OVEREXPRESSION; HUMAN; LETTER; LYMPH NODE METASTASIS; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT PLANNING;

EID: 0033590919     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.8.728     Document Type: Letter

References (0)